[Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
Budanov
S V
SV
Research Centre of Drug Evaluation and State Control, National Research Centre of Antibiotics, Moscow.
Smirnova
L B
LB
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006094:Gram-Positive Bacteria / Q000187:drug effects; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D064704:Levofloxacin; D015242:Ofloxacin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D000890:Anti-Infective Agents; D064704:Levofloxacin; D015242:Ofloxacin